1. Nolvadex reduces IGF-1 production, which diminish the hypertrophic response. This IGF lowering effect is in fact one of the reasons for the use of tamoxifen to help with breast cancer. ER-negative breast cancer cells are responsive to IGF-1 (IGF-1 makes them grow), the fact that tamoxifen lowers circulating IGF-1 is the reason for its use as an anti-cancer medicine (Pollack et al. 1990)
2. Nolvadex (and other anti-E/anti-A) reduces bloating... while bloating isn't muscle mass, it can contribute to stimulating growth via 2 pathways: a) increasing intramuscular pressure (also called cell volumization) has been shown to increase protein synthesis (Stoll et al. 1992) and decrease muscle breakdown (Hallbrucker et al. 1990, Hallbrucker et al. 1991, vom Dahl et al. 1991, Häussinger et al. 1990, vom Dahl et al. 1995), whereas a ''flat'' muscle leads to a catabolic state ... to quote Haussinger et al (1996) ''cell shrinkage inhibits, whereas cell swelling stimulates, protein synthesis ''.
b) ''Bloating'' improves joint stability and force levers which allows you to lift more weight either by desentisizing the protective mechanisms of the muscle (the more stable joint makes the CNS ''believes'' that it's safe to produce more force) or by improved leverage. This is why several powerlifters actually ''bloat'' on purpose prior to a contest (after they weight in). The capacity to lift more weight = more potential growth stimulation.
3. Estrogen is needed, to some extent, for optimal muscle growth.